Dermata Therapeutics, Inc. (DRMA)
Nasdaq: DRMA · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2021
Who owns Dermata Therapeutics, Inc.
As filed with the SECHolders of 5% or more
2
Proehl Gerald T holds 17.3% of Common Stock, Par Value $0.0001 Per Share., as its SCHEDULE 13D/A filed Feb 23, 2026 says.
Directors and officers
11
report now, of 12 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Proehl Gerald T
SCHEDULE 13D/A · filed Feb 23, 2026 · Common Stock, Par Value $0.0001 Per Share. · 19.6% in Feb 2, 2026
Kyri K. Van Hoose
SCHEDULE 13D · filed Jun 1, 2026 · Common Stock, $0.0001 par value per share
Mitchell P. Kopin
SCHEDULE 13G/A · filed May 13, 2026 · Common stock, par value $0.0001 per share · reported falling below 5%, from 5.5% in Jan 2, 2026
Armistice Capital, LLC
SCHEDULE 13G/A · filed Feb 18, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 4.99% in Feb 17, 2026
Bigger Capital Fund L P
SCHEDULE 13G/A · filed Apr 22, 2026 · Common Stock, $0.0001 par value · reported falling below 5%, from 9.89% in Feb 9, 2026
What DRMA reports owning in othersstakes of 5% or more, and other ties
Dermata Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
1sales
1purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | 0 | $0 | 0 | 1 | $0 |
| Scott Kathleen D. | director | 1 | $0 | 0 | 0 | $0 |